| abstract |
The present invention covers 5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds of general formula (I) and general formula (l-a): in which A, R1 and R2 are as defined herein, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, and compounds of general formula (l-c) and general formula (l-d): in which R1 and R2 are as defined herein, for the treatment and/or prophylaxis of diseases, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions. |